5726 - 5750 of 8471 Results
Title
Year
-
OPENTitle: SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 526End Page: 535Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27642Best OA location URL: https://europepmc.org/articles/pmc6469643?pdf=renderCitation Count: 101
-
RESTRICTEDTitle: Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindredJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: 133End Page: 134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.024Citation Count: 2
-
OPENTitle: High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia NigraJournal Name: RadiologyPublisher: Radiological Society of North America (RSNA)Vol: 291Issue #: 1Start Page: 149End Page: 157Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1148/radiol.2019181042Best OA location URL: https://europepmc.org/articles/pmc6438360?pdf=renderCitation Count: 46
-
OPENTitle: Awake Testing during Deep Brain Stimulation Surgery Predicts Postoperative Stimulation Side Effect ThresholdsJournal Name: Brain SciencesPublisher: MDPI AGVol: 9Issue #: 2Start Page: 44End Page: 44Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci9020044Best OA location URL: https://www.mdpi.com/2076-3425/9/2/44/pdf?version=1550479268Citation Count: 13
-
RESTRICTEDTitle: T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's DiseaseJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2019.00239Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2019.00239/pdfCitation Count: 97
-
RESTRICTEDTitle: Higher urate in LRRK2 mutation carriers resistant to Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 4Start Page: 593End Page: 599Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.25436Citation Count: 52
-
OPENTitle: Progressive brain atrophy in chronically infected and treated HIV+ individualsJournal Name: Journal of NeuroVirologyPublisher: Springer Science and Business Media LLCVol: 25Issue #: 3Start Page: 342End Page: 353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13365-019-00723-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6635004Citation Count: 35
-
OPENTitle: OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 174End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.009Best OA location URL: https://zenodo.org/records/3832127/files/R1-OnabotulinumtoxinA_and_Cognitive_Behavioral_Therapy_in_Functional_Dystonia_A_Pilot_Randomized_Clinical_Trial_pdf.io.pdfCitation Count: 17
-
RESTRICTEDTitle: Transplant and risk of Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 149End Page: 155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.013Citation Count: 6
-
RESTRICTEDTitle: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseasesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 7Start Page: 329End Page: 337Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000006926Best OA location URL: https://europepmc.org/articles/pmc6382364?pdf=renderCitation Count: 196
- Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson’s disease2019OPENTitle: Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 2Start Page: e0211699End Page: e0211699Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0211699Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0211699&type=printableCitation Count: 9
-
OPENTitle: Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 3End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.001Best OA location URL: https://doi.org/10.1016/j.parkreldis.2019.02.001Citation Count: 23
-
OPENTitle: Neural correlates of distinct cognitive phenotypes in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 399Issue #:Start Page: 22End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.02.013Citation Count: 10
-
OPENTitle: Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 879End Page: 899Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-019-01962-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6533145Citation Count: 102
-
OPENTitle: An estimate of the total number of true human miRNAsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 47Issue #: 7Start Page: 3353End Page: 3364Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/nar/gkz097Best OA location URL: https://academic.oup.com/nar/article-pdf/47/7/3353/28467549/gkz097.pdfCitation Count: 494
-
RESTRICTEDTitle: A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 9Issue #: 1Start Page: 63End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181448Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181448?id=journal-of-parkinsons-disease%2Fjpd181448Citation Count: 11
-
OPENTitle: Cholinergic system changes of falls and freezing of gait in Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 4Start Page: 538End Page: 549Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25430Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25430Citation Count: 151
-
OPENTitle: l ‐3,4‐dihydroxyphenylalanine ( l ‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 150Issue #: 1Start Page: 88End Page: 106Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1111/jnc.14676Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14676Citation Count: 31
- Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph2019OPENTitle: Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorphJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-019-0469-0Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-019-0469-0Citation Count: 127
-
OPENTitle: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8AJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 294Issue #: 13Start Page: 4738End Page: 4758Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.ra118.005008Best OA location URL: https://europepmc.org/articles/pmc6442034?pdf=renderCitation Count: 69
-
RESTRICTEDTitle: A review of basal ganglia circuits and physiology: Application to deep brain stimulationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 59Issue #:Start Page: 9End Page: 20Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.009Best OA location URL: https://europepmc.org/articles/pmc7020857?pdf=renderCitation Count: 46
-
RESTRICTEDTitle: Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluidJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 59Issue #:Start Page: 21End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.11.016Citation Count: 16
-
OPENTitle: Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansionJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 699Issue #:Start Page: 134End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2019.01.056Best OA location URL: https://europepmc.org/articles/pmc6443492?pdf=renderCitation Count: 9
-
OPENTitle: Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's DiseaseJournal Name: Clinical and Translational SciencePublisher: WileyVol: 12Issue #: 3Start Page: 240End Page: 246Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/cts.12619Best OA location URL: https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.12619Citation Count: 18
-
RESTRICTEDTitle: No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 74Issue #:Start Page: 236.e1End Page: 236.e5Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.09.022Best OA location URL: http://manuscript.elsevier.com/S0197458018303476/pdf/S0197458018303476.pdfCitation Count: 1